Brief: Cvrx Reiterates Plans To Discuss The Preliminary Results From The Post-Market Phase Of The Beat-Hf Trial At Tht 2023 And Schedules A Conference Call
16/03/2023 13:14
March 16 (Reuters) - CVRx Inc CVRX.O :
* CVRX REITERATES PLANS TO DISCUSS THE PRELIMINARY RESULTS
FROM
THE POST-MARKET PHASE OF THE BEAT-HF TRIAL AT THT 2023 AND
SCHEDULES A CONFERENCE CALL
Source text for Eikon: ID:nGNX7MtNNp
Further company coverage: CVRX.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on CVRx
See all newsBrief: CVRx Announces Humana Medicare Advantage Coverage Policy For Barostim Therapy
CVRx's Q1 revenue rises 20%, beats expectations
Brief: CVRx Q1 Revenue USD 14.769 Million Vs. IBES Estimate USD 14.5 Million
CVRx preliminary Q1 revenue rises 20%, gross margin improves
CVRx Q4 revenue rises 4%, beats expectations